Scabies: Important Clinical Consequences Explained by New Molecular Studies

Advances in Parasitology

Volumn 79, Issue , 2012, Pages 339-373

  Fischer, Katja ^a   Holt, Deborah ^b   Currie, Bart ^b   Kemp, David ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE; COMPLEMENT COMPONENT C9; CROTAMITON; CYSTEINE PROTEINASE; DEXAMETHASONE; FILAGGRIN; HOUSE DUST ALLERGEN; IVERMECTIN; MANNAN BINDING LECTIN; PERITROPHIN; PERMETHRIN; PROTEIN; SAR S 3 PROTEIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TEA TREE OIL; UNCLASSIFIED DRUG;

ARTHROPOD LIFE CYCLE STAGE; ARTICLE; BACTERIAL GROWTH; BACTERIAL SKIN DISEASE; COMPLEMENT SYSTEM; DIAGNOSTIC TEST; DNA LIBRARY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GROUP A STREPTOCOCCAL INFECTION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; SARCOPTES SCABIEI; SCABIES; SERODIAGNOSIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; SURVIVAL;

EID: 84862657133     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398457-9.00005-6     Document Type: Chapter

References (161)

1. Alexander J.O. Arthropods and Human Skin 1984, Berlin and Heidelberg, Springer-Verlag.
2. Amer M., El-Gharib I. Permethrin versus crotamiton and lindane in the treatment of scabies. Int. J. Dermat. 1992, 31:357-358.
3. Andrews R.M., Kearns T., Connors C., Parker C., Carville K., Currie B.J. A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl. Trop. Dis. 2009, 3:e554.
4. Arlian L., Runyan R., Achar S., Estes S. Survival and infectivity of Sarcoptes scabiei var. canis and var. hominis. J. Am. Acad. Dermatol. 1984, 11:210-215.
5. Arlian L., Vyszenski-Moher D., Rapp C.M., Hull B. Production of IL-1 alpha and IL-1 beta by human skin equivalents parasitized by. Sarcoptes scabiei. J. Parasitol. 1996, 82:719-723.
6. Arlian L., Morgan M., Neal J. Modulation of cytokine expression in human keratinocytes and fibroblasts by extracts of scabies mites. Am. J. Trop. Med. Hyg. 2003, 69:652-656.
7. Arlian L., Morgan M., Neal J. Extracts of scabies mites (Sarcoptidae: Sarcoptes scabiei) modulate cytokine expression by human peripheral blood mononuclear cells and dendritic cells. J. Med. Entomol. 2004, 41:69-73.
8. Arlian L., Morgan M., Paul C. Evidence that scabies mites (Acari: Sarcoptidae) influence production of interleukin-10 and the function of T-regulatory cells (Tr1) in humans. J. Med. Entomol. 2006, 43.
9. Arlian L.G., Runyan R.A., Estes S.A. Cross infestivity of Sarcoptes scabiei. J. Am. Acad. Dermatol. 1984, 10:979-986.
10. Arlian L.G., Estes S.A., Vyszenski-Moher D.L. Prevalence of Sarcoptes scabiei in the homes and nursing homes of scabietic patients. J. Am. Acad. Dermatol. 1988, 19:806-811.
11. Arlian L.G. Biology, host relations, and epidemiology of Sarcoptes scabiei. Ann. Rev. Entomol. 1989, 34:139-161.
12. Arlian L.G., Vyszenski-Moher D.L., Pole M.J. Survival of adults and development stages of Sarcoptes scabiei var. canis when off the host. Exp. Appl. Acarol. 1989, 6:181-187.
13. Armon A., Graur D., Ben-Tal N. ConSurf: an algorithmic tool for the identification of functional regions in proteins by surface mapping of phylogenetic information. J. Mol. Biol. 2001, 307:447-463.
14. Arnold J.N., Dwek R.A., Rudd P.M., Sim R.B. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol. Lett. 2006, 106:103-110.
15. Beckham S.A., Boyd S.E., Reynolds S., Willis C., Johnstone M., Mika A., et al. Characterization of a serine protease homologous to house dust mite group 3 allergens from the scabies mite Sarcoptes scabiei. J. Biol. Chem. 2009, 284:34413-34422.
16. Bell R.E., Ben-Tal N. In silico identification of functional protein interfaces. Comp. Funct. Genomics. 2003, 4:420-423.
17. Bergstrom F.C., Reynolds S., Johnstone M., Pike R.N., Buckle A.M., Kemp D.J., et al. Scabies mite inactivated serine protease paralogs inhibit the human complement system. J. Immunol. 2009, 182:7809-7817.
18. Bornstein S., Zakrisson G., Thebo P. Clinical picture and antibody response to experimental Sarcoptes scabiei var. vulpes infection in red foxes (Vulpes vulpes). Acta. Vet. Scand. 1995, 36:509-519.
19. Bornstein S., Thebo P., Zakrisson G. Evaluation of an enzyme-linked immunosorbant (ELISA) for the serological diagnosis of canine sarcoptic mange. Vet. Dermatol. 1996, 7:21-27.
20. Bornstein S., Wallgreen P. Serodiagnosis of sarcoptic mange in pigs. Vet. Rec. 1997, 141:8-12.
21. Bornstein S.,M.T., Samuel Wm Parasitic diseases of wild mammals 2001, Iowa State University Press, Iowa: Ames. W.M. Samuel, P.M., A.A. Kocan (Eds.).
22. Brandt E.R., Hayman W.A., Currie B., Carapetis J., Wood Y., Jackson D.C., et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunol. 1996, 89:331-337.
23. Brindley P.J., Kalinna B.H., Wong J.Y., Bogitsh B.J., King L.T., Smyth D.J., et al. Proteolysis of human hemoglobin by schistosome cathepsin D. Mol. Biochem. Parasitol. 2001, 112:103-112.
24. Brinkworth R.I., Harrop S.A., Prociv P., Brindley P.J. Host specificity in blood feeding parasites: a defining contribution by haemoglobin-degrading enzymes?. Int. J. Parasitol. 2000, 30:785-790.
25. Brinkworth R.I., Prociv P., Loukas A., Brindley P.J. Hemoglobin-degrading, aspartic proteases of blood-feeding parasites: substrate specificity revealed by homology models. J. Biol. Chem. 2001, 276:38844-38851.
26. Brown A., Girod N., Billett E.E., Pritchard D.I. Necator americanus (human hookworm) aspartyl proteinases and digestion of skin macromolecules during skin penetration. Am. J. Trop. Med. Hyg. 1999, 60:840-847.
27. Burgess I. Sarcoptes scabiei and scabies. Adv. Parasitol. 1994, 33:235-292.
28. Candi E., Schmidt R., Melino G. The cornified envelope: a model of cell death in the skin. Nat. Rev. Mol. Cell Biol. 2005, 6:328-340.
29. Carapetis J.R., Connors C., Yarmirr D., Krause V., Currie B.J. Success of a scabies control program in an Australian aboriginal community. Pediatr. Infect. Dis. J. 1997, 16:494-499.
30. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 2005, 5:685-694.
31. Carapetis J.R., Brown A., Wilson N.J., Edwards K.N. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med. J. Aust. 2007, 186:581-586.
32. Carlsson F., Berggard K., Stalhammar-Carlemalm M., Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J. Exp. Med. 2003, 198:1057-1068.
33. Casais R., Prieto M., Balseiro A., Solano P., Parra F., Martin Alonso J.M. Identification and heterologous expression of a Sarcoptes scabiei cDNA encoding a structural antigen with immunodiagnostic potential. Vet. Res. 2007, 38:435-450.
34. Christopherson J. Epidemiology of Scabies. Parasitol. Today 1986, 2:247-248.
35. Cilurzo F., Minghetti P., Sinico C. Newborn pig skin as model membrane in in vitro drug permeation studies: a technical note. AAPS Pharm. Sci. Tech. 2007, 8:E94.
36. Clucas D.B., Carville K.S., Connors C., Currie B.J., Carapetis J.R., Andrews R.M. Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull. World Health Organ. 2008, 86:275-281.
37. Coley A.M., Campanale N.V., Casey J.L., Hodder A.N., Crewther P.E., Anders R.F., et al. Rapid and precise epitope mapping of monoclonal antibodies against Plasmodium falciparum AMA1 by combined phage display of fragments and random peptides. Protein Eng. 2001, 14:691-698.
38. Currie B., Carapetis J. Skin infections and infestations in Aboriginal communities in northern Australia. Australas. J. Dermatol. 2000, 41:139-143. quiz 144-135.
39. Currie B., Harumal P., McKinnon M., Walton S. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. 2004, 39:e8-12.
40. Currie B.J., Maguire G.P., Wood Y.K. Ivermectin and crusted (Norwegian) scabies. Med. J. Aust. 1995, 163:559-560.
41. Currie B.J., McCarthy J.S. Permethrin and ivermectin for scabies. N. Engl. J. Med. 2010, 362:717-725.
42. Curtis C.F. Evaluation of a commercially available enzyme-linked immunosorbent assay for the diagnosis of canine sarcoptic mange. Vet. Rec. 2001, 148:238-239.
43. De Rose R., McKenna R.V., Cobon G., Tennent J., Zakrzewski H., Gale K., et al. Bm86 antigen induces a protective immune response against Boophilus microplus following DNA and protein vaccination in sheep. Vet. Immunol. Immunopathol. 1999, 71:151-160.
44. Deperthes D. Phage display substrate: a blind method for determining protease specificity. Biol. Chem. 2002, 383:1107-1112.
45. Elder B., Arlian L., Morgan M. Sarcoptes scabiei (Acari: Sarcoptidae) mite extract modulates expression of cytokines and adhesion molecules by human dermal microvascular endothelial cells. J. Med. Entomol. 2006, 43:910-915.
46. Ewald D. CARPA Standard Treatment Manual 2010, Central Australian Rural Practitioners Association Inc., Alice Springs. fifth ed.
47. Favoreel H.W., Van De Walle G.R., Nauwynck H.J., Pensaert M.B. Virus complement evasion strategies. J. Gen. Virol. 2003, 84:1-15.
48. Fimiani M., Mazzatenta C., Alessandrini C., Paccagnini E., Andreassi L. The behaviour of Sarcoptes scabiei var. hominis in human skin: an ultrastructural study. J. Submicrosc. Cytol. Pathol. 1997, 29:105-113.
49. Fischer K., Holt D.C., Harumal P., Currie B.J., Walton S.F., Kemp D.J. Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am. J. Trop. Med. Hyg. 2003, 68:61-64.
50. Fischer K., Holt D.C., Wilson P., Davis J., Hewitt V., Johnson M., et al. Normalization of a cDNA library cloned in lambda ZAP by a long PCR and cDNA reassociation procedure. Bio. Tec. 2003, 34:250-252. 254.
51. Fischer K., Langendorf C.G., Irving J.A., Reynolds S., Willis C., Beckham S., et al. Structural mechanisms of inactivation in scabies mite serine protease paralogues. J. Mol. Biol. 2009, 390:635-645.
52. Francis S.E., Gluzman I.Y., Oksman A., Knickerbocker A., Mueller R., Bryant M.L., et al. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J. 1994, 13:306-317.
53. Frentz G., Veien N.K., Eriksen K. Immunofluorescence studies in scabies. J. Cutan. Pathol. 1977, 4:191-193.
54. Gao J., Scott J.G. Use of quantitative real-time polymerase chain reaction to estimate the genome size of the house-fly Musca domestica genome. Insect. Mol. Biol. 2006, 15:835-837.
55. Geraci N.S., Johnston S.J., Robinson J.P., Wikel S.K., Hill C.A. Variation in genome size of agrasid and ixodid ticks. Insect Biochem. Mol. Biol. 2007, 37:399-408.
56. Haas N., Wagemann B., Hermes B., Henz B.M., Heile C., Schein E. Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch. Dermatol. Res. 2005, 296:327-331.
57. Hanrahan S.J., Johnston S.J. New genome size estimates of 134 species of arthropods. Chromosome Res. 2011, 19:809-823.
58. Harumal P., Morgan M., Walton S.F., Holt D.C., Rode J., Arlian L.G., et al. Identification of a homologue of a house dust mite allergen in a cDNA library from Sarcoptes scabiei var. hominis and evaluation of its vaccine potential in a rabbit/S. scabiei var. canis model. Am. J. Trop. Med. Hyg. 2003, 68:54-60.
59. Hekim C., Leinonen J., Narvanen A., Koistinen H., Zhu L., Koivunen E., et al. Novel peptide inhibitors of human kallikrein 2. J. Biol. Chem. 2006, 281:12555-12560.
60. Hoefling K., Schroeter A. Dermatoimmunopathology of scabies. J. Am. Acad. Dermatol. 1980, 3:237-240.
61. Holers V.M., Kulik L. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol. Immunol. 2007, 44:64-72.
62. Hollander D.A., Erli H.J., Theisen A., Falk S., Kreck T., Muller S. Standardized qualitative evaluation of scar tissue properties in an animal wound healing model. Wound Repair Regen. 2003, 11:150-157.
63. Hollanders W., Vercruysse J., Raes S., Bornstein S. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the serological diagnosis of sarcoptic mange in swine. Vet. Parasitol. 1997, 69:117-123.
64. Holmskov U., Malhotra R., Sim R.B., Jensenius J.C. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol. Today 1994, 15:67-74.
65. Holt D.C., Fischer K., Allen G.E., Wilson D., Wilson P., Slade R., et al. Mechanisms for a novel immune evasion strategy in the scabies mite Sarcoptes scabiei: a multigene family of inactivated serine proteases. J. Invest. Dermatol. 2003, 121:1419-1424.
66. Holt D.C., Fischer K., Pizzutto S.J., Currie B.J., Walton S.F., Kemp D.J. A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J. Invest. Dermatol. 2004, 123:240-241.
67. Huffam S.E., Currie B.J. Ivermectin for Sarcoptes scabiei hyperinfestation. Int. J. Infect. Dis. 1998, 2:152-154.
68. Jacobson M., Bornstein S., Wallgren P. The efficacy of simplified eradication strategies against sarcoptic mange mite infections in swine herds monitored by an ELISA. Vet. Parasitol. 1999, 81:249-258.
69. Jayaraj R., Hales B., Viberg L., Pizzuto S., Holt D., Rolland J.M., et al. A diagnostic test for scabies: IgE specificity for a recombinant allergen of Sarcoptes scabiei. Diagn. Microbiol. Infect. Dis. 2011, 71:403-407.
70. Jeyaprakash A., Hoy M. The nuclear genome of the phytoseiid Metaseiulus occidentalis (Acari: Phytoseiidae) is amongst the smallest known in arthropods. Exp. Appl. Acarol. 2009, 47:263-273.
71. Jiang H., Zhang H.M., Frank M.M. Subcutaneous infusion of human C1 inhibitor in swine. Clin. Immunol. 2010, 136:323-328.
72. Jolodar A., Fischer P., Buttner D.W., Miller D.J., Schmetz C., Brattig N.W. Onchocerca volvulus: expression and immunolocalization of a nematode cathepsin D-like lysosomal aspartic protease. Exp. Parasitol. 2004, 107:145-156.
73. Kearns T., Andrews R., Speare R., Cheng A., McCarthy J., Carapetis J. Beating scabies and strongyloidiasis in the Northern Territory, Australia with an ivermectin MDA. Trop. Med. Int. Health 2009, 14:196.
74. Kemp D.H., Pearson R.D., Gough J.M., Willadsen P. Vaccination against Boophilus microplus: localization of antigens on tick gut cells and their interaction with the host immune system. Exp. Appl. Acarol. 1989, 7:43-58.
75. Kemper C., Atkinson J.P. T-cell regulation: with complements from innate immunity. Nat. Rev. Immunol. 2007, 7:9-18.
76. Kirschfink M., Mollnes T.E. Modern complement analysis. Clin. Diagn. Lab. Immunol. 2003, 10:982-989.
77. La Vincente S., Kearns T., Connors C., Cameron S., Carapetis J., Andrews R. Community Management of Endemic Scabies in Remote Aboriginal Communities of Northern Australia: low treatment uptake and high ongoing acquisition. PLoS Negl. Trop. Dis. 2009, 3:e444.
78. Lalli P., Morgan M., Arlian L. Skewed Th1/Th2 immune response to Sarcoptes scabiei. J. Parasitol. 2004, 90:711-714.
79. Lambris J.D., Ricklin D., Geisbrecht B.V. Complement evasion by human pathogens. Nat. Rev. Microbiol. 2008, 6:132-142.
80. Lancefield R.C. Differentiation of group A streptococci with a common R antigen into three serological types, with special reference to the bactericidal test. J. Exp. Med. 1957, 106:525-544.
81. Lawrence G., Leafasia J., Sheridan J., Hills S., Wate J., Wate C., et al. Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull. World Health Organ. 2005, 83:34-42.
82. Levi A., Mumcuoglu K.Y., Ingber A., Enk C.D. Assessment of Sarcoptes scabiei viability in vivo by reflectance confocal microscopy. Lasers. Med. Sci. 2011, 26:291-292.
83. List K., Szabo R., Wertz P.W., Segre J., Haudenschild C.C., Kim S.Y., et al. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J. Cell Biol. 2003, 163:901-910.
84. Ljunggren E.L., Nilsson D., Mattsson J.G. Expressed sequence tag analysis of Sarcoptes scabiei. Parasitol. 2003, 127:139-145.
85. Longbottom D., Redmond D.L., Russell M., Liddell S., Smith W.D., Knox D.P. Molecular cloning and characterisation of a putative aspartate proteinase associated with a gut membrane protein complex from adult Haemonchus contortus. Mol. Biochem. Parasitol. 1997, 88:63-72.
86. Loukas A., Bethony J.M., Mendez S., Fujiwara R.T., Goud G.N., Ranjit N., et al. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2005, 2:e295.
87. Lower K.S., Medleau L.M., Hnilica K., Bigler B. Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the serological diagnosis of sarcoptic mange in dogs. Vet. Dermatol. 2001, 12:315-320.
88. Manzano-Roman R., Encinas-Grandes A., Perez-Sanchez R. Antigens from the midgut membranes of Ornithodoros erraticus induce lethal anti-tick immune responses in pigs and mice. Vet. Parasitol. 2006, 135:65-79.
89. Marshall C.S., Cheng A.C., Markey P.G., Towers R.J., Richardson L.J., Fagan P.K., et al. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am. J. Trop. Med. Hyg. 2011, 85:703-710.
90. Mattsson J.G., Ljunggren E.L., Bergstrom K. Paramyosin from the parasitic mite Sarcoptes scabiei: cDNA cloning and heterologous expression. Parasitology 2001, 122:555-562.
91. McDonald M.I., Towers R.J., Fagan P., Carapetis J.R., Currie B.J. Molecular typing of Streptococcus pyogenes from remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infection. Epidemiol. Infect. 2007, 135:1398-1405.
92. McGrath J.A., Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol. Med. 2008, 14:20-27.
93. Mellanby K. Transmission of Scabies. Br. Med. J. 1941, 2:405-406.
94. Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 1944, 35:197-206.
95. Mellanby K. Scabies in 1976. R. Soc. Health J. 1977, 47:32-36.
96. Mellanby K. Epidemiology of scabies. Scabies and Pediculosis 1977, JB Lippincott, Philadelphia. M. Orkin, H.I. Maibach, L.C. Parish, R.M. Schwartzman (Eds.).
97. Mika A., Goh P., Holt D.C., Kemp D.J., Fischer K. Scabies mite peritrophins are potential targets of human host innate immunity. PLoS Negl. Trop. Dis. 2011, 5:e1331.
98. Mika, A., Reynolds, S., Bergstrom, F.C., Willis, C., Halilovic, V., Pickering, D.A., et al. Novel Scabies mite serpins inhibit all three pathways of the human complement system. Manuscript in review.
99. Mika, A., Reynolds, S., Pickering, D.A., McMillan, D.J., Sriprakash, K.S., Kemp, D.J., et al. Complement inhibitors from scabies mites promote streptococcal growth - a novel mechanism in infected epidermis? PLoS Negl Trop Dis, in press.
100. Molin E.U., Mattsson J.G. Effect of acaricides on the activity of glutathione transferases from the parasitic mite Sarcoptes scabiei. Parasitology 2008, 135:115-123.
101. Mounsey K., Holt D., McCarthy J., Currie B., Walton S. Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol. 2008, 3:57-66.
102. Mounsey K., Ho M.F., Kelly A., Willis C., Pasay C., Kemp D.J., et al. A tractable experimental model for study of human and animal scabies. PLoS Negl. Trop. Dis. 2010, 4:e756.
103. Mounsey K.E., Holt D.C., McCarthy J., Walton S.F. Identification of ABC transporters in Sarcoptes scabiei. Parasitology 2006, 132:883-892.
104. Mounsey K.E., Dent J.A., Holt D.C., McCarthy J., Currie B.J., Walton S.F. Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei. Invert. Neurosci. 2007, 7:149-156.
105. Mounsey K.E., Holt D.C., McCarthy J.S., Currie B.J., Walton S.F. Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch. Dermatol. 2009, 145:840-841.
106. Mounsey K.E., Pasay C.J., Arlian L.G., Morgan M.S., Holt D.C., Currie B.J., et al. Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors 2010, 3:43.
107. Mounsey K.E., Willis C., Burgess S.T., Holt D.C., McCarthy J., Fischer K. Quantitative PCR-based genome size estimation of the astigmatid mites Sarcoptes scabiei, Psoroptes ovis and Dermatophagoides pteronyssinus. Parasit Vectors 2012, 5:3.
108. Nomura T., Akiyama M., Sandilands A., Nemoto-Hasebe I., Sakai K., Nagasaki A., et al. Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J. Invest. Dermatol. 2008, 128:1436-1441.
109. Normaznah Y., Saniah K., Nazma M., Mak J.W., Krishnasamy M., Hakim S.L. Seroprevalence of Sarcoptes scabiei var canis antibodies among aborigines in peninsular Malaysia. Southeast Asian J. Trop. Med. Public Health 1996, 27:53-56.
110. Orkin M. Special forms of scabies. Cutaneous Infestation and Insect Bites 1985, Marcel Dekker, New York. M.M. Orkin, I. Howard (Eds.).
111. Oyelami O.A., Onayemi A., Oyedeji O.A., Adeyemi L.A. Preliminary study of effectiveness of aloe vera in scabies treatment. Phytother. Res. 2009, 23:1482-1484.
112. Parnaby M.G., Carapetis J.R. Rheumatic fever in indigenous Australian children. J. Paediatr. Child Health 2010, 46:527-533.
113. Pasay C., Arlian L., Morgan M., Vyszenski-Moher D., Rose A., Holt D., et al. High-resolution melt analysis for the detection of a mutation associated with permethrin resistance in a population of scabies mites. Med. Vet. Entomol. 2008, 22:82-88.
114. Pasay C., Mounsey K., Stevenson G., Davis R., Arlian L., Morgan M., et al. Acaricidal activity of eugenol based compounds against scabies mites. PLoS ONE 2010, 5:e12079.
115. Pearson M.S., Bethony J.M., Pickering D.A., De Oliveira L.M., Jariwala A., Santiago H., et al. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 2009, 23:3007-3019.
116. Pearson M.S., Pickering D.A., Tribolet L., Cooper L., Mulvenna J., Oliveira L.M., et al. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. J. Infect. Dis. 2010, 201:1561-1569.
117. Popadiak K., Potempa J., Riesbeck K., Blom A.M. Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J. Immunol. 2007, 178:7242-7250.
118. Prins C., Stucki L., French L., Saurat J.H., Braun R.P. Dermoscopy for the in vivo detection of Sarcoptes scabiei. Dermatology 2004, 208:241-243.
119. Rapp C.M., Morgan M.S., Arlian L.G. Presence of host immunoglobulin in the gut of Sarcoptes scabiei (Acari: Sarcoptidae). J. Med. Entomol. 2006, 43:539-542.
120. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
121. Roberts L.J., Huffam S.E., Walton S.F., Currie B.J. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J. Infect. 2005, 50:375-381.
122. Rooijakkers S.H., Van Strijp J.A. Bacterial complement evasion. Mol. Immunol. 2007, 44:23-32.
123. Salo O., Reunala T., Kalimo K., Rantanen T. Immunoglobulin and complement deposits in the skin and circulating immune complexes in scabies. Acta Derm. Venereol. 1982, 62:73-76.
124. Salvesen B., Mollnes T.E. Pathway-specific complement activity in pigs evaluated with a human functional complement assay. Mol. Immunol. 2009, 46:1620-1625.
125. Scaramuzzino D.A., McNiff J.M., Bessen D.E. Humanized in vivo model for streptococcal impetigo. Infect. Immun. 2000, 68:2880-2887.
126. Simon G.A., Maibach H.I. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations - an overview. Skin Pharmacol. Appl. Skin. Physiol. 2000, 13:229-234.
127. Skelly P.J. Intravascular schistosomes and complement. Trends Parasitol. 2004, 20:370-374.
128. Steer A.C., Jenney A.W., Kado J., Batzloff M.R., La Vincente S., Waqatakirewa L., et al. High burden of impetigo and scabies in a tropical country. PLoS Negl. Trop. Dis. 2009, 3:e467.
129. Steinstraesser L., Vranckx J.J., Mohammadi-Tabrisi A., Jacobsen F., Mittler D., Lehnhardt M., et al. A novel titanium wound chamber for the study of wound infections in pigs. Comp. Med. 2006, 56:279-285.
130. Sullivan T.P., Eaglstein W.H., Davis S.C., Mertz P. The pig as a model for human wound healing. Wound Repair Regen. 2001, 9:66-76.
131. Taplin D., Meinking T.L., Chen J.A., Sanchez R. Comparison of crotamiton 10% cream (eurax) and permethrin 5% cream (elimite) for the treatment of scabies in children. Pediatr. Dermatol. 1990, 7:67-73.
132. Terada Y., Murayama N., Ikemura H., Morita T., Nagata M. Sarcoptes scabiei var. canis refractory to ivermectin treatment in two dogs. Vet. Dermatol. 2010, 21:608-612.
133. Thorgersen E.B., Ghebremariam Y.T., Thurman J.M., Fung M., Nielsen E.W., Holers V.M., et al. Candidate inhibitors of porcine complement. Mol. Immunol. 2007, 44:1827-1834.
134. Turner M.W. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol. Today 1996, 17:532-540.
135. Van Buynder P.G., Gaggin J.A., Martin D., Pugsley D., Mathews J.D. Streptococcal infection and renal disease markers in Australian aboriginal children. Med. J. Aust. 1992, 156:537-540.
136. Van Den Hoek J.A., Van De Weerd J.A., Baayen T.D., Molenaar P.M., Sonder G.J., Van Ouwerkerk I.M., et al. A persistent problem with scabies in and outside a nursing home in Amsterdam: indications for resistance to lindane and ivermectin. Euro. Surveill. 2008, 13:19052.
137. Van Der Heijden H.M., Rambags P.G., Elbers A.R., Van Maanen C., Hunneman W.A. Validation of ELISAs for the detection of antibodies to Sarcoptes scabiei in pigs. Vet. Parasitol. 2000, 89:95-107.
138. Van Neste D. Behaviour of Sarcoptes scabiei in its burrow in hyperkeratotic scabies. A scanning electron microscopic study. Dermatologica. 1985, 171:343-348.
139. Van Neste D.J., Staquet M.J. Similar epidermal changes in hyperkeratotic scabies of humans and pigs. Comp. Dermatopathol. 1986, 8:267-273.
140. Vodicka P., Smetana K., Dvorankova B., Emerick T., Xu Y.Z., Ourednik J., et al. The miniature pig as an animal model in biomedical research. Ann. N. Y. Acad. Sci. 2005, 1049:161-171.
141. Walton S., Currie B., Kemp D. A DNA fingerprinting system for the ectoparasite Sarcoptes scabiei. Mol. Biochem. Parasitol. 1997, 85:187-196.
142. Walton S., Dougall A., Pizzutto S., Holt D., Taplin D., Arlian L., et al. Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int. J. Parasitol. 2004, 34:839-849.
143. Walton S., Beroukas D., Roberts-Thomson P., Currie B. New insights into disease pathogenesis in crusted (Norwegian) scabies: the skin immune response in crusted scabies. Br. J. Dermatol. 2008, 158:1247-1255.
144. Walton S.F., Choy J.L., Bonson A., Valle A., McBroom J., Taplin D., et al. Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am. J. Trop. Med. Hyg. 1999, 61:542-547.
145. Walton S.F., Myerscough M.R., Currie B.J. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:92-96.
146. Walton S.F., Dougall A., Pizzutto S., Holt D., Taplin D., Arlian L.G., et al. Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int. J. Parasitol. 2004, 34:839-849.
147. Walton S.F., Holt D.C., Currie B.J., Kemp D.J., Baker J.R., et al. Scabies: New Future for a Neglected Disease. Advances in Parasitology 2004, Academic Press.
148. Walton S.F., McKinnon M., Pizzutto S., Dougall A., Williams E., Currie B.J. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of Sarcoptes scabiei var. hominis to terpinen-4-ol. Arch. Dermatol. 2004, 140:563-566.
149. Walton S.F., Currie B.J. Problems in diagnosing scabies, a global disease in human and animal populations. Clin. Microbiol. Rev. 2007, 20:268-279.
150. Walton S.F. The immunology of susceptibility and resistance to scabies. Parasite Immunol. 2010, 999.
151. Walton S.F., Pizzutto S., Slender A., Viberg L., Holt D., Hales B.J., et al. Increased allergic immune response to Sarcoptes scabiei antigens in crusted versus ordinary scabies. Clin. Vaccine Immunol. 2010, 17:1428-1438.
152. Wikel S.K. Acquired resistance to ticks: expression of resistance by C4-deficient guinea pigs. Am. J. Trop. Med. Hyg. 1979, 28:586-590.
153. Wilhelm J., Pingoud A., Hahn M. Real-time PCR-based method for the estimation of genome sizes. Nucleic Acids Res. 2003, 31:e56.
154. Willadsen P., Smith D., Cobon G., McKenna R.V. Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86 alone or in combination with recombinant Bm91. Parasite Immunol. 1996, 18:241-246.
155. Williamson A.L., Brindley P.J., Abbenante G., Prociv P., Berry C., Girdwood K., et al. Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity. FASEB J. 2002, 16:1458-1460.
156. Williamson A.L., Brindley P.J., Loukas A. Hookworm cathepsin D aspartic proteases: contributing roles in the host-specific degradation of serum proteins and skin macromolecules. Parasitology 2003, 126:179-185.
157. Willis C., Fischer K., Walton S.F., Currie B.J., Kemp D.J. Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am. J. Trop. Med. Hyg. 2006, 75:683-687.
158. Wong L.C., Amega B., Connors C., Barker R., Dulla M.E., Ninnal A., et al. Outcome of an interventional program for scabies in an Indigenous community. Med. J. Aust. 2001, 175:367-370.
159. Wong L.C., Amega B., Barker R., Connors C., Dulla M.E., Ninnal A., et al. Factors supporting sustainability of a community-based scabies control program. Australas. J. Dermatol. 2002, 43:274-277.
160. Xiao S., Zhan B., Xue J., Goud G.N., Loukas A., Liu Y., et al. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus. Exp. Parasitol. 2008, 118:32-40.
161. Zipfel P.F., Wurzner R., Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 2007, 44:3850-3857.